Chronic Heart Failure Clinical Trial
Official title:
The Effect of High-intensity Interval Training and Moderate Intensity Continuous Training on Cardiopulmonary Functions in Chronic Heart Failure
The aim of this study is to investigate the effect of high-intensity interval training and moderate intensity continuous training on cardiopulmonary functions in chronic heart failure.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2025 |
Est. primary completion date | July 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 70 Years |
Eligibility | Inclusion Criteria: - medically stable chronic heart failure - NYHA II-III - can perform cardiopulmonary exercise test - after 3months with proper medication - age 30 to 70 - ejection fraction< 40% Exclusion Criteria: - contraindication to cardiopulmonary exercise test - musculoskeletal problem who cannot perform cardiopulmonary exercise test - cognition deficit who cannot understand directions - severe medial illness |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Inha University hospital | Incheon | Kyunggi-do |
Lead Sponsor | Collaborator |
---|---|
Inha University Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Maximal or peak oxygen consumption (VO2max or VO2peak, same meaning) (kg/ml/min) | at the end of training, from baseline to 12 weeks | compare baseline data with 12 weeks rehabilitation data | |
Secondary | Anaerobic threshold (kg/ml/min) | The anaerobic threshold is the highest exercise intensity that you can sustain for a prolonged period without lactate substantially building up in your blood. | compare baseline data with 12 weeks rehabilitation data | |
Secondary | 6minute walk test (meter) | compare baseline data with 12 weeks rehabilitation data | ||
Secondary | maximal heart rate (bpm) | compare baseline data with 12 weeks rehabilitation data | ||
Secondary | systolic blood pressure (mmHg) | compare baseline data with 12 weeks rehabilitation data | ||
Secondary | diastolic blood pressure (mmHg) | compare baseline data with 12 weeks rehabilitation data | ||
Secondary | resting heart rate (bpm) | compare baseline data with 12 weeks rehabilitation data | ||
Secondary | diastolic blood presure (mmHg) | compare baseline data with 12 weeks rehabilitation data | ||
Secondary | depression scale by Patient Health Questionnaire | Patient Health Questionnaire (PHQ; range, 0-27; higher score = severe depression; cut-off score of 5 for minimal depression) | compare baseline data with 12 weeks rehabilitation data | |
Secondary | anxiety scale by Generalized Anxiety Disorder Scale | Generalized Anxiety Disorder Scale (GAD; range, 0-21; higher score = severe anxiety; cut-off score of 5 for mild anxiety) | compare baseline data with 12 weeks rehabilitation data | |
Secondary | fatigue scale by fatigue severity scale | fatigue severity scale (FSS; range, 9-63; higher score = severe fatigue; cut-off score of 4 for fatigue) | compare baseline data with 12 weeks rehabilitation data | |
Secondary | Quality of Life (QoL) questionnaire (MacNew) | MacNew QoL questionnaire is a measurement tool for patients with cardiac disease that measures physical, emotional, and social functional levels to provide overall QoL. | compare baseline data with 12 weeks rehabilitation data |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03597646 -
The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure
|
N/A | |
Terminated |
NCT04065997 -
Apogee International
|
||
Withdrawn |
NCT03675113 -
Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02916160 -
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
|
Phase 4 | |
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Completed |
NCT02247245 -
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
|
N/A | |
Completed |
NCT02268500 -
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
|
Phase 4 | |
Completed |
NCT01919918 -
Muscle Afferent Feedback Effects in Patients With Heart Failure
|
Phase 1 | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT00984529 -
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02840565 -
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
|
Phase 1 | |
Completed |
NCT02441218 -
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
|
Phase 3 | |
Completed |
NCT00149409 -
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT05532046 -
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
|
Phase 1 | |
Recruiting |
NCT04984928 -
Readmission Risk of Patients With Heart Failure.
|
||
Completed |
NCT02814097 -
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05560737 -
ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|